Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CNXU

Conexeu Sciences Inc

May 22 • 03:24PM ET

13.90

+0.83 6.37 %

Healthcare • Medical Devices • USA • Micro • NASD

May 21, 12:05 PMConexeu Sciences begins trading on Nasdaq today under ticker CNXU with approximately 25.3 million shares outstanding.

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	20.92M	Perf Week	-
Market Cap	290.84M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	284.13M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	42.60	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	6.37%
Book/sh	0.33	P/C	43.34	EPS next 5Y	-	ROE	-	52W High	17.50 -20.56%	Perf Year	-
Cash/sh	0.32	P/FCF	-	EPS past 3/5Y	-950.49% -	ROIC	-	52W Low	12.31 12.94%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	3.48	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.51	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	8.51	EPS Q/Q	-	SMA20	3.09%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	3.09%	Rel Volume	0.29	Prev Close	13.07
Employees	4	LT Debt/Eq	0.00	Earnings	-	SMA200	3.09%	Avg Volume	87.90K	Price	13.90
IPO	May 21, 2026	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	23,447	Change	6.37%

Today 10:31AM	Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It (PR Newswire) +6.37%
May-21-26 12:02PM	Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol 'CNXU' (Newsfile)

Conexeu Sciences, Inc. engages in the development of regenerative biomaterials needed in wound care, dentistry, and aesthetics. The company was founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell on November 2, 2022 and is headquartered in Reno, NV.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CNXU

Conexeu Sciences Inc

Upgrade your Finviz experience